ArticleJSES international2025
Evaluation of glenohumeral adduction restriction in frozen shoulder as a predictor of intra-articular lesion severity: a comparison study of the freezing and frozen phases.
Article in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glenohumeral adduction restriction (AR), which is found in rotator cuff tears, is also observed in frozen shoulder (FS). AR was examined using an adduction test and treated through adduction manipulation. We aimed to compare the incidence and severity of AR and investigate clinical characteristics and outcomes of the freezing and frozen phases. Methods: Two hundred sixteen patients with FS were enrolled in this study; consequently, 120 were classified into the freezing phase (mean age 58 years, 37 men) and 56 into the frozen phase (mean age 55.4 years, 29 men). Using the adduction test, the patients in 2 phases were divided into 2 groups, with and without AR. The glenohumeral adduction angle (GAA) was measured radiographically. Treatments in the freezing phase were physiotherapy and/or adduction manipulation and joint manipulation and physiotherapy for the frozen phase. We recorded the visual analog scale of pain severity, EuroQol-visual analog scale, flexion, abduction, external rotation (ER), internal rotation, and American Shoulder and Elbow Surgeons and Constant scores at the baseline and at the 1-, 3-, 6-, 12-, and 24-month follow-ups. Results: Seventy-five of 120 patients in the freezing phase were divided into group 1 without AR and 45 into group 2 with AR. Eight of 56 patients in the frozen phase were classified into group 3 without AR and 48 into group 4 with AR. AR was identified in 37.5% of patients in the freezing phase and 85.7% in the frozen phase. The mean GAA decreased from the freezing (-3.0°) to the frozen phases (-18.3°). GAA was positively correlated with ER. The treatment duration in group 1 (5.2 M) was shorter than in group 2 (7.4 M), and the percentage of transition to joint manipulation in group 1 (5.3%) was lower than in group 2 (17.8%). Complete rupture of intra-articular soft tissues was observed in group 4 but not in group 3 with magnetic resonance imaging. Clinical items, except for ER in the freezing phase (group 1 vs. 2) and frozen phase (group 3 vs. 4), were not significantly different from those at the initial visit to the 24-month follow-up appointment. Conclusion: The incidence and severity of AR increase from the freezing phase to the frozen phase. AR correlating with ER reflects the progression of intra-articular lesions, which prolongs the treatment duration and increases the joint manipulation rate in the freezing phase. Negative AR in the frozen phase suggests mild intra-articular pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.